References
- Baker M.A., Zeman E.M., Hirst V.K., Brown J.M. Metabolism of SR 4233 by Chinese hamster ovary cells: the basis of selective hypoxic cytotoxicity. Cancer Research 1988; 48: 5947–5952
- Brown J.M. Evidence for acutely hypoxic cells in mouse tumors, and a possible mechanism of reoxygenation. British Journal of Radiology 1979; 52: 650–656
- Brown J.M. Exploitation of bioreductive agents with vasoactive drugs. Proceedings of the 8th International Congress of Radiation Research, EdinburghUK. Taylor & Francis, London 1987; 2: 719–724
- Brown J.M. Hypoxic cell radiosensitizers: where next?. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 987–993
- Brown J.M., Hall E.J., Hirst D.G., Kinsella T.J., Kligerman M.M., Mitchell J.B., Travis E.L., Valeriote F. Chemical modification of radiation and chemotherapy. American Journal of Clinical Oncology (Cancer Clinical Trials) 1988; 11: 288–303
- Brown, J.M., Lemmon, M.J. Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation. International Journal of Radiation Oncology, Biology, Physics, In press, 1990
- Brown J.M., Lemmon M.J., Tracy M. In vivo activity of the novel bioreductive cytotoxic drug SR 4233 (Abstract). Proceedings of the American Association for Cancer Research 1989; 30: 585–585
- Chaplin D.J., Durand R.E., Olive P.L. Acute hypoxia in tumors: implications for modifiers of radiation effects. International Journal of Radiation Oncology, Biology, Physics 1986; 12: 1279–1282
- Chaplin D.J., Olive P.L., Durand R.E. Intermittent blood flow in a murine tumor. Radiobiological effects. Cancer Research 1987; 47: 597–601
- Fertil B., Malaise E.P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. International Journal of Radiation Oncology, Biology, Physics 1981; 7: 621–629
- Fertil B., Malaise E.P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. International Journal of Radiation Oncology, Biology, Physics 1985; 11: 1699–1707
- Koch C. A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. Radiation Research 1984; 97: 434–442
- Laderoute K.R., Wardman P., Rauth A.M. Molecular mechanisms for the selective toxicity of 3-amino-1,2,4-benzotriazine 1,4-dioxide towards hypoxic cells. Biochemical Pharmacology 1988; 37: 1487–1495
- Malaise E.P. The non-hypoxic cell sensitizers: their use in radiobiology and in radiotherapy. Proceedings of the 8th International Congress of Radiation Research, EdinburghUK. Taylor & Francis, London 1987; 2: 750–755
- Malaise E.P., Fertil B., Chavaundra N., Guichard M. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data. International Journal of Radiation Oncology, Biology, Physics 1986; 12: 617–624
- Stratford I.J., Stephens M.A. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 973–976
- Walton M.I., Wolf C.R., Workman P. Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 983–986
- Zeman E.M., Baker M.A., Lemmon M.J., Pearson C.I., Adams J.A., Brown J.M., Lee W.W., Tracy M. Structure-activity relationships for benzotriazine di-N-oxides. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 977–981
- Zeman E.M., Brown J.M. Pre- and post-irradiation radiosensitization by SR 4233. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 967–971
- Zeman E.M., Brown J.M., Lemmon M.J., Hirst V.K., Lee W.W. SR 4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncology, Biology, Physics 1986; 12: 1239–1242
- Zeman E.M., Hirst V.K., Lemmon M.J., Brown J.M. Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233. Radiotherapy and Oncology 1988; 12: 209–218
- Zeman E.M., Lemmon M.J., Brown J.M. Aerobic radiosensitization by SR 4233 in vitro and in vivo. International Journal of Radiation Oncology, Biology, Physics 1990a; 18: 125–132
- Zeman E.M., Pearson C.I., Brown J.M. Induction of hypoxia in glass versus permanox petri dishes. Radiation Research 1990b; 122: 72–76